A detailed history of Great West Life Assurance CO transactions in Catalent, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 105,676 shares of CTLT stock, worth $6.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
105,676
Previous 110,841 4.66%
Holding current value
$6.71 Million
Previous $6.23 Million 2.71%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $290,066 - $314,858
-5,165 Reduced 4.66%
105,676 $6.4 Million
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $1.15 Million - $1.22 Million
21,390 Added 23.91%
110,841 $6.23 Million
Q1 2024

May 13, 2024

BUY
$42.56 - $59.82 $32,515 - $45,702
764 Added 0.86%
89,451 $5.05 Million
Q4 2023

Feb 13, 2024

SELL
$32.18 - $46.57 $471,276 - $682,017
-14,645 Reduced 14.17%
88,687 $3.97 Million
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $65,813 - $74,747
-1,489 Reduced 1.42%
103,332 $4.71 Million
Q2 2023

Aug 10, 2023

BUY
$31.86 - $67.26 $157,515 - $332,533
4,944 Added 4.95%
104,821 $4.57 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $336,710 - $550,266
7,410 Added 8.01%
99,877 $6.57 Million
Q4 2022

Feb 10, 2023

BUY
$41.39 - $81.0 $13,493 - $26,406
326 Added 0.35%
92,467 $4.19 Million
Q3 2022

Nov 01, 2022

SELL
$72.36 - $113.1 $95,804 - $149,744
-1,324 Reduced 1.42%
92,141 $6.67 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $8.15 Million - $10.7 Million
93,465 New
93,465 $10 Million
Q2 2022

Aug 09, 2022

SELL
$87.2 - $114.05 $9.6 Million - $12.6 Million
-110,092 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$94.19 - $124.49 $885,951 - $1.17 Million
-9,406 Reduced 7.87%
110,092 $12.9 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $4.52 Million - $5.26 Million
37,816 Added 46.3%
119,498 $15.3 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $1.32 Million - $1.72 Million
-12,057 Reduced 12.86%
81,682 $10.9 Million
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $1.79 Million - $2.06 Million
-17,841 Reduced 15.99%
93,739 $10.1 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $4.31 Million - $5.32 Million
42,481 Added 61.48%
111,580 $11.7 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $1.42 Million - $1.74 Million
16,507 Added 31.39%
69,099 $7.17 Million
Q3 2020

Nov 17, 2020

SELL
$72.74 - $92.5 $44.7 Million - $56.9 Million
-614,736 Reduced 92.12%
52,592 $4.51 Million
Q3 2020

Nov 13, 2020

BUY
$72.74 - $92.5 $41.2 Million - $52.4 Million
566,642 Added 562.78%
667,328 $57.2 Million
Q2 2020

Aug 17, 2020

BUY
$48.02 - $79.04 $993,677 - $1.64 Million
20,693 Added 25.87%
100,686 $7.37 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $318,324 - $542,314
8,615 Added 12.07%
79,993 $4.15 Million
Q4 2019

Feb 11, 2020

BUY
$47.06 - $56.64 $3.36 Million - $4.04 Million
71,378 New
71,378 $4.02 Million
Q3 2019

Oct 25, 2019

SELL
$47.45 - $58.05 $4.06 Million - $4.96 Million
-85,462 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$39.26 - $54.21 $75,850 - $104,733
-1,932 Reduced 2.21%
85,462 $0
Q1 2019

May 08, 2019

SELL
$29.84 - $43.92 $72,033 - $106,022
-2,414 Reduced 2.69%
87,394 $3.55 Million
Q4 2018

Feb 12, 2019

BUY
$29.95 - $46.34 $290,395 - $449,312
9,696 Added 12.1%
89,808 $2.6 Million
Q3 2018

Nov 13, 2018

SELL
$40.12 - $45.55 $554,378 - $629,409
-13,818 Reduced 14.71%
80,112 $3.65 Million
Q2 2018

Aug 10, 2018

SELL
$38.72 - $42.52 $56,569 - $62,121
-1,461 Reduced 1.53%
93,930 $3.94 Million
Q1 2018

May 10, 2018

SELL
$39.4 - $47.39 $156,418 - $188,138
-3,970 Reduced 4.0%
95,391 $3.92 Million
Q4 2017

Feb 09, 2018

BUY
$37.27 - $43.02 $319,292 - $368,552
8,567 Added 9.44%
99,361 $4.08 Million
Q3 2017

Nov 09, 2017

BUY
$33.75 - $41.67 $3.06 Million - $3.78 Million
90,794
90,794 $3.59 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.